Consilium Wealth Advisory LLC raised its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 110.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,458 shares of the semiconductor company's stock after buying an additional 3,918 shares during the period. Consilium Wealth Advisory LLC's holdings in Lam Research were worth $1,593,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in LRCX. Brighton Jones LLC lifted its position in shares of Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company's stock worth $1,025,000 after purchasing an additional 12,936 shares during the period. Caxton Associates LLP acquired a new stake in shares of Lam Research during the first quarter worth $239,000. Gabelli Funds LLC acquired a new stake in shares of Lam Research during the second quarter worth $253,000. NewEdge Advisors LLC raised its stake in Lam Research by 2.7% during the second quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company's stock worth $9,785,000 after buying an additional 2,661 shares during the last quarter. Finally, Osterweis Capital Management Inc. lifted its holdings in Lam Research by 5,206.7% in the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company's stock valued at $77,000 after buying an additional 781 shares during the period. Institutional investors and hedge funds own 84.61% of the company's stock.
Insider Buying and Selling at Lam Research
In related news, Director Eric Brandt sold 54,500 shares of the stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction on Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the sale, the senior vice president directly owned 58,470 shares of the company's stock, valued at approximately $18,102,312. The trade was a 11.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 86,339 shares of company stock valued at $27,680,267. Company insiders own 0.31% of the company's stock.
Analyst Upgrades and Downgrades
LRCX has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft upped their price target on shares of Lam Research from $300.00 to $325.00 and gave the company a "buy" rating in a research report on Thursday, April 23rd. Wells Fargo & Company reissued an "overweight" rating and issued a $450.00 price objective (up from $365.00) on shares of Lam Research in a research note on Monday. Evercore upped their target price on Lam Research from $275.00 to $300.00 and gave the company an "outperform" rating in a research report on Thursday, April 23rd. Zacks Research cut Lam Research from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 6th. Finally, Royal Bank Of Canada lifted their target price on Lam Research from $290.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, April 23rd. Twenty-eight investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $334.43.
Check Out Our Latest Stock Report on LRCX
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Bank of America raised its price target on Lam Research from $330 to $480 and reiterated a buy rating, reinforcing Wall Street’s bullish view on the company’s AI- and memory-driven growth outlook. Read More
- Positive Sentiment: Other recent analyst updates also stayed constructive, including Citi’s $450 target and earlier target hikes from Wells Fargo, Cantor Fitzgerald, UBS, and others, suggesting continued confidence in Lam Research’s demand environment. Article Title
- Neutral Sentiment: Recent commentary highlighted Lam Research’s strong fundamentals, including solid revenue growth and upbeat AI spending trends, but these positives were not enough to offset the day’s sector-wide decline. Article Title
- Negative Sentiment: Lam Research shares were hit by a global chip selloff and profit-taking after a strong run, with investors de-risking from AI and memory-related names across the semiconductor group. Article Title
Lam Research Price Performance
Shares of NASDAQ LRCX opened at $371.33 on Wednesday. The firm has a market capitalization of $464.37 billion, a P/E ratio of 70.06, a P/E/G ratio of 3.37 and a beta of 1.85. The firm's 50-day moving average price is $306.92 and its 200-day moving average price is $245.44. The company has a current ratio of 2.54, a quick ratio of 1.77 and a debt-to-equity ratio of 0.35. Lam Research Corporation has a 1-year low of $90.93 and a 1-year high of $409.75.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, beating the consensus estimate of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. During the same period last year, the business posted $1.04 EPS. The firm's revenue for the quarter was up 23.8% compared to the same quarter last year. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Equities research analysts anticipate that Lam Research Corporation will post 5.7 earnings per share for the current fiscal year.
Lam Research Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th will be paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Wednesday, June 17th. Lam Research's dividend payout ratio (DPR) is 19.62%.
Lam Research Company Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report